Pharmafile Logo
Pharmafocus logo
Advanced Search

Takeda

Showing 15 posts of 249 posts found.

Takeda HQ image

Takeda to buy LigoCyte for $60 million

October 8, 2012
Sales and Marketing LigoCyte, Takeda, norovirus

Takeda Pharmaceutical Company is to pay $60 million upfront to buy private US biopharma firm LigoCyte Pharmaceuticals in the next …

News
Takeda HQ image

Takeda opens Russian manufacturing facility

September 11, 2012
Manufacturing and Production Actovegin, Nycomed, Russia, Takeda

Takeda Pharmaceutical has officially opened its new manufacturing facility in Yaroslavl, Russia, and expects it to be operating at full …

News
Takeda's Actos

Generic Actos gains FDA approval

August 20, 2012
Sales and Marketing Actos, Mylan, Ranbaxy, Takeda, diabetes, generic

Takeda’s big-selling diabetes pill Actos will have its US sales decimated after the FDA approves three copycat versions of the …

News
Velcade image

Speedy approval for Onyx’ multiple myeloma drug

July 24, 2012
Research and Development, Sales and Marketing FDA, Janssen, Kyprolis, Onyx, Takeda, Velcade

Onyx’ Kyprolis has gained an accelerated approval by the FDA to treat patients with late-stage multiple myeloma.  Kyprolis (carfilzomib), a …

News
david_milton

Senior appointments for Takeda’s Europe and Canada team

July 18, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda Pharmaceuticals has appointed David Milton as head of Marketing & Product Portfolio Strategy, and Dr Nizamul Islam as head …

Appointment
rob_gallo_takeda

Takeda appoints new head of Corporate Communications, Europe and Canada

July 12, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, communications

Takeda Pharmaceuticals has appointed Rob Gallo as head of Corporate Communications, Europe and Canada. Since 2010 Gallo has been the …

Appointment
EMA image

EMA publishes updated diabetes guidelines

July 2, 2012
Research and Development, Sales and Marketing Avandia, EMA, GSK, R&D, Takeda

The European Medicines Agency has published new guidance on what it wants to see from firms submitting new diabetes treatments. …

News

Takeda makes changes to organisation

June 22, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda has announced the change of senior leadership and the establishment of a new organisation.Effective from July Masahiro Fujimaki becomes …

Appointment
AstraZeneca image

AstraZeneca buys Ardea Biosciences

June 22, 2012
Research and Development, Sales and Marketing Abbott, Ardea Biosciences, AstraZeneca, Bayer, Humira, Takeda

AstraZeneca has completed its acquisition of US firm Ardea Biosciences in a $1.26 billion deal that it hopes will shore …

News
takeda_tokyo_hq

Takeda to buy gout specialist URL Pharma for $800m

April 16, 2012
Research and Development, Sales and Marketing R&D, Takeda, acquisition, gout

Takeda is set to purchase URL Pharmaceuticals for $800 million, helping offset the loss of its blockbuster ulcer drug Prevacid.  …

News

Approval for Affymax and Takeda’s anaemia treatment

March 29, 2012
Sales and Marketing Affymax, Amgen, ESA, Epogen, Takeda, omontys

The first rival treatment to Amgen’s portfolio of anaemia drugs has been approved in the US.Omontys (peginesatide) has been developed …

News
Takeda image

Takeda to cut 2,800 jobs

January 19, 2012
Business Services, Research and Development, Sales and Marketing Nycomed, Takeda, job cuts

Takeda has announced plans to significantly reduce its global headcount over the next four years following its merger with Nycomed. …

News

Pharma unprepared for annus horribilis

January 12, 2012
Research and Development, Sales and Marketing AZ, Pfizer, Takeda, patents, pharma

A new survey shows pharma is not prepared to deal with the tough year ahead as many blockbuster drugs begin …

News

Dr Rajeev Venkayya to head Takeda’s new vaccine business

December 9, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda will establish a new vaccine business division in January next year and will appoint Dr Rajeev Venkayya as its …

Appointment
Takeda

Takeda completes Nycomed acquisition, installs new chief executive

October 3, 2011
Sales and Marketing Nycomed, Takeda

Takeda Pharmaceutical Company has completed its acquisition of Nycomed and named Frank Morich as chief executive of the Zurich-based firm. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025